Enzymatic self-assembly of nanostructures for theranostics

Theranostics

Volumn 2, Issue 2, 2012, Pages 139-147

  Chen, Yue ^a   Liang, Gaolin ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Diagnosis; Enzyme; Nanostructures; Self assembly; Theranostics; Therapy

Indexed keywords

NANOPARTICLE;

COVALENT BOND; DOWN REGULATION; ENZYMATIC ASSAY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SYNTHESIS; HUMAN; MACROMOLECULE; NANOCHEMISTRY; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; REVIEW;

EID: 84864559415     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3696     Document Type: Review

References (53)

1. Walsh C. Enabling the chemistry of life. Nature. 2001; 409: 226-31.
2. Whitesides GM, Mathias JP and Seto CT. Molecular self-assembly and nanochemistry - A chemical strategy for the synthesis of nanostructures. Science. 1991; 254: 1312-19.
3. Timpl R and Brown JC. Supramolecular assembly of basement membranes. Bioessays. 1996; 18: 123-32.
4. Schnur JM. Lipid tubules - A paradigm for molecularly engineered structures. Science. 1993; 262: 1669-76.
5. Qi S, Groves JT and Chakraborty AK. Synaptic pattern formation during cellular recognition. Proc Natl Acad Sci U S A. 2001; 98: 6548-53.
6. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H and Wanker EE. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology. Proc Natl Acad Sci U S A. 1999; 96: 4604-09.
7. Yang Z, Liang G, Guo Z, Guo Z and Xu B. Intracellular hydrogelation of small molecules inhibits bacterial growth. Angew Chem Int Edit. 2007; 46: 8216-19.
8. Spruell JM and Hawker CJ. Triggered structural and property changes in polymeric nanomaterials. Chem Sci. 2011; 2: 18-26.
9. Liang G, Ren H and Rao J. A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat Chem. 2010; 2: 54-60.
10. Razgulin A, Ma N and Rao J. Strategies for in vivo imaging of enzyme activity: an overview and recent advances. Chem Soc Rev. 2011; 40: 4186-216.
11. Lee S, Xie J and Chen X. Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem Rev. 2010; 110: 3087-111.
12. Koo H, Huh MS, Ryu JH, Lee D-E, Sun I-C, Choi K, Kim K and Kwon IC. Nanoprobes for biomedical imaging in living systems. Nano Today. 2011; 6: 204-20.
13. Ye Y and Chen X. Integrin targeting for tumor optical imaging. Theranostics. 2011; 1: 102-06.
14. Jeong H, Huh M, Lee SJ, Koo H, Kwon IC, Jeong SY and Kim K. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy. Theranostics. 2011; 1: 230-39.
15. Bhirde A, Guo N and Chen X. Targeted nanoprobes reveal early time point kinetics in vivo by time-resolved MRI. Theranostics. 2011; 1: 274-76.
16. Schnepp ZAC, Gonzalez-McQuire R and Mann S. Hybrid biocomposites based on calcium phosphate mineralization of self-assembled supramolecular hydrogels. Adv Mater. 2006; 18: 1869-72.
17. Yang Z and Xu B. A simple visual assay based on small molecule hydrogels for detecting inhibitors of enzymes. Chem Commun. 2004;: 2424-25.
18. Yang Z, Liang G, Ma M, Gao Y and Xu B. In vitro and in vivo enzymatic formation of supramolecular hydrogels based on self-assembled nanofibers of a beta-amino acid derivative. Small. 2007; 3: 558-62.
19. Yang Z, Liang G, Wang L and Xu B. Using a kinase/phosphatase switch to regulate a supramolecular hydrogel and forming the supramoleclar hydrogel in vivo. J Am Chem Soc. 2006; 128: 3038-43.
20. Yang Z, Ho P, Liang G, Chow K, Wang Q, Cao Y, Guo Z and Xu B. Using beta-lactamase to trigger supramolecular hydrogelation. J Am Chem Soc. 2007; 129: 266-67.
21. Toledano S, Williams RJ, Jayawarna V and Ulijn RV. Enzyme-triggered self-assembly of peptide hydrogels via reversed hydrolysis. J Am Chem Soc. 2006; 128: 1070-71.
22. de Loos M, Friggeri A, van Esch J, Kellogg RM and Feringa BL. Cyclohexane bis-urea compounds for the gelation of water and aqueous solutions. Org Biomol Chem. 2005; 3: 1631-39.
23. Yang Z, Xu K, Guo Z, Guo Z and Xu B. Intracellular enzymatic formation of nanofibers results in hydrogelation and regulated cell death. Adv Mater. 2007; 19: 3152-56.
24. Ye D, Liang G, Ma M and Rao J. Controlling intracellular macrocyclization for the imaging of protease activity. Angew Chem Int Edit. 2011; 50: 2275-79.
25. Yang Z, Liang G and Xu B. Enzymatic hydrogelation of small molecules. Accounts Chem Res. 2008; 41: 315-26.
26. Yang S and Zhang S. Self-assembling behavior of designer lipid-like peptides. Supramol Chem. 2006; 18: 389-96.
27. Becker AL, Johnston APR and Caruso F. Peptide nucleic acid films and capsules: assembly and enzymatic degradation. Macromol Biosci. 2010; 10: 488-95.
28. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997; 326: 1-16.
29. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW and Mak TW. Essential contribution of caspase 3 CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998; 12: 806-19.
30. Wang C, Guttridge DC, Mayo MW and Baldwin AS. NF-kappa B induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol. 1999; 19: 5923-29.
31. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD and Wong WW. Substrate specificities of caspase family proteases. J Biol Chem. 1997; 272: 9677-82.
32. Cao C, Chen Y, Wu F, Deng Y and Liang G. Caspase-3 controlled assembly of nanoparticles for fluorescence turn on. Chem Commun. 2011; 47: 10320-22.
33. Baskin JM, Prescher JA, Laughlin ST, Agard NJ, Chang PV, Miller IA, Lo A, Codelli JA and Bertozzi CR. Copper-free click chemistry for dynamic in vivo imaging. Proc Natl Acad Sci U S A. 2007; 104: 16793-97.
34. Thomas G. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol. 2002; 3: 753-66.
35. Shapiro J, Sciaky N, Lee J, Bosshart H, Angeletti RH and Bonifacino JS. Localization of endogenous furin in cultured cell lines. J Histochem Cytochem. 1997; 45: 3-12.
36. Dragulescu-Andrasi A, Liang G and Rao J. In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates. Bioconjugate Chem. 2009; 20: 1660-66.
37. Mbikay M, Sirois F, Yao J, Seidah NG and Chretien M. Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997; 75: 1509-14.
38. Bassi DE, Mahloogi H, Al-Saleem L, De Cicco RL, Ridge JA and Klein-Szanto AJP. Elevated furin expression in aggressive human head and neck tumors and tumors cell lines. Mol Carcinog. 2001; 31: 224-32.
39. Bassi DE, De Cicco RL, Mahloogi H, Zucker S, Thomas G and Klein-Szanto AJP. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci U S A. 2001; 98: 10326-31.
40. Sounni NE, Baramova EN, Munaut C, Maquoi E, Frankenne F, Foidart JM and Noel A. Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Int J Cancer. 2002; 98: 23-28.
41. Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K and Nakayama K. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem. 1991; 266: 12127-30.
42. Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW and Vogelstein B. A phosphatase associated with metastasis of colorectal cancer. Science. 2001; 294: 1343-46.
43. Hutton JC and Eisenbarth GS. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci U S A. 2003; 100: 8626-28.
44. Yuan J and Yankner BA. Apoptosis in the nervous system. Nature. 2000; 407: 802-09.
45. Auch CJ, Saha RN, Sheikh FG, Liu X, Jacobs BL and Pahan K. Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia. FEBS Lett. 2004; 563: 223-28.
46. Jessani N, Liu Y, Humphrey M and Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci U S A. 2002; 99: 10335-40.
47. Rowinsky EK and Donehower RC. Drug-therapy - paclitaxel (taxol). N Engl J Med. 1995; 332: 1004-14.
48. Gao Y, Kuang Y, Guo Z, Guo Z, Krauss IJ and Xu B. Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative. J Am Chem Soc. 2009; 131: 13576-77.
49. Helblingleclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FMS, Schwartz K, Fardeau M, Tryggvason K and Guicheney P. Mutations in the laminin alpha-2-chain gene (LAMA2) cause merosin-deficient congenital muscular-dystrophy. Nature Genet. 1995; 11: 216-18.
50. Robbins PB, Sheu SM, Goodnough JB and Khavari PA. Impact of laminin 5 beta 3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa. Hum Gene Ther. 2001; 12: 1443-48.
51. Igoucheva O, Kelly A, Uitto J and Alexeev V. Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant beta 3 chain into laminin 332 in beta 3-/- keratinocytes in vitro. J Invest Dermatol. 2008; 128: 1476-86.
52. Rooney JE, Gurpur PB and Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2009; 106: 7991-96.
53. Williams RJ, Hall TE, Glattauer V, White J, Pasic PJ, Sorensen AB, Waddington L, McLean KM, Currie PD and Hartley PG. The in vivo performance of an enzyme-assisted self-assembled peptide/protein hydrogel. Biomaterials. 2011; 32: 5304-10.